SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/13/15 Samana Capital, L.P. SC 13G 1:109K ChemoCentryx, Inc. Fried Fr… Jacobson/NY/FA Morton Holdings, Inc. Philip B. Korsant |
Document/Exhibit Description Pages Size 1: SC 13G Statement of Beneficial Ownership HTML 58K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
ChemoCentryx, Inc.
|
Common Stock, par value $0.001 per share
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Samana Capital, L.P.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING PERSON
WITH |
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
28,881
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0.1% (1)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
PN
|
|
|
|||
|
|
(1)
|
As of November 5, 2015, the event date which triggered the current filing obligation, Samana Capital, L.P. may be deemed to have beneficially owned 2,384,577 shares of ChemoCentryx, Inc. Common Stock, par value $0.001 per share, or approximately 5.4% of the 44,131,962 shares outstanding as of November 4, 2015, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2015. As of the date of this filing, Samana Capital, L.P. may be deemed to beneficially owns 28,881 shares of Common Stock of the Issuer, par value $0.001 per share, or approximately 0.1% of the shares outstanding as of November 4, 2015.
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Morton Holdings, Inc.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING PERSON
WITH |
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
28,881
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0.1% (1)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
(1)
|
As of November 5, 2015, the event date which triggered the current filing obligation, Morton Holdings, Inc. may be deemed to have beneficially owned 2,384,577 shares of ChemoCentryx, Inc. Common Stock, par value $0.001 per share, or approximately 5.4% of the 44,131,962 shares outstanding as of November 4, 2015, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2015. As of the date of this filing, Morton Holdings, Inc. may be deemed to beneficially own 28,881 shares of Common Stock of the Issuer, par value $0.001 per share, or approximately 0.1% of the shares outstanding as of November 4, 2015.
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
|
|
||||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States of America
|
|
|
|||
|
|
||||
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING PERSON
WITH |
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
28,881
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
28,881
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0.1% (1)
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
(1)
|
As of November 5, 2015, the event date which triggered the current filing obligation, Philip B. Korsant may be deemed to have beneficially owned 2,384,577 shares of ChemoCentryx, Inc. Common Stock, par value $0.001 per share, or approximately 5.4% of the 44,131,962 shares outstanding as of November 4, 2015, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2015. As of the date of this filing, Philip B. Korsant may be deemed to beneficially own 28,881 shares of Common Stock of the Issuer, par value $0.001 per share, or approximately 0.1% of the shares
outstanding as of November 4, 2015.
|
Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: |
(a)
|
Amount beneficially owned:
|
|
|
||
See Item 9 of the attached cover pages.
|
||
(b)
|
Percent of class:
|
|
|
||
See Item 11 of the attached cover pages.
|
||
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote:
|
|
See Item 5 of the attached cover pages.
|
||
(ii)
|
Shared power to vote or to direct the vote:
|
|
See Item 6 of the attached cover pages.
|
||
(iii)
|
Sole power to dispose or to direct the disposition:
|
|
See Item 7 of the attached cover pages.
|
||
(iv)
|
Shared power to dispose or to direct the disposition:
|
|
See Item 8 of the attached cover pages.
|
SAMANA CAPITAL, L.P.
By: Morton Holdings, Inc., its general partner
|
|||
|
By:
|
/s/ David Gray | |
Name: David Gray | |||
Title: Vice President | |||
SAMANA CAPITAL, L.P.
By: Morton Holdings, Inc., its general partner
|
|||
|
By:
|
/s/ David Gray | |
Name: David Gray | |||
Title: Vice President | |||
This ‘SC 13G’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/13/15 | |||
11/9/15 | 10-Q, 8-K, SC 13G/A | |||
11/5/15 | 4 | |||
11/4/15 | ||||
List all Filings |